
Driven by our commitment to patients and our strong business foundation, we’re dedicated to furthering Alzheimer’s disease, Parkinson's Disease research and advancing our pipeline. We aim to help address the unmet needs in this devastating condition, with an emphasis on the earliest stages of the disease.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.